Afzal Guru event row: JNU bars Kanhaiya, 7 others from classes

February 14, 2016

New Delhi, Feb 14: Even as the agitation in Jawaharlal Nehru University over the eulogizing of Afzal Guru took on an increasingly political colour on Saturday, the university's own high-level inquiry decided that eight students, including two top members of the students' union — its president Kanhaiya Kumar and general secretary Rama Naga — had prima facie engaged in "objectionable sloganeering" on the campus on February 9.jnu

The decision is likely to harden the stand of JNUSU, which has called for a strike on Monday which will continue "till Kumar is released unconditionally".

"The high-level inquiry conducted by a three-member committee submitted its interim report on Friday evening and recommended debarring eight student from academic activities," announced Bupinder Zutshi, registrar of the university. "The report is based on prima facie evidence based on JNU's own video footage. The interim report recommended the measures because of objectionable sloganeering and indiscipline."

Beside Kumar and Naga, the others implicated are Sayed Umar Khalid, one of the organizers of the controversial event, Anirban Bhattacharya, Ashutosh Kumar, Ananth Prakash Narayan, Aishwarya Adhikari and Shweta Raj. Though debarred from academic activities, they have not been asked to vacate their hostel to enable them to participate in the inquiry.

Refuting the teachers and students who are demanding that the police should leave the campus, Zutshi claimed that there was no police presence on the university premises. He said the cops had only gone to one hostel, Brahmaputra, to pick up Kumar after duly informing the institution's officials.

"The police contacted us and said it was necessary to interrogate some students as they were being charged with sedition," said Zutshi. "They asked for our help in identifying Kanhaiya Kumar and also asked us about the whereabouts of 20 others. We asked the police to act as per law. We submitted to them on Thursday itself the video footage we had and whatever other details we possessed."

The registrar added that the vice-chancellor had met the deans and chairpersons of various centres on Friday and apprised them of the situation on the ground.

Earlier in the day, K Kasturirangan, chancellor of the university, visited the campus and met officials, teachers and students. He held meetings with representatives of the agitating teachers' association JNUTA, the staff association as well as teachers who did not subscribe to the views of JNUTA. Saurabh Sharma, joint secretary of JNUSU, the only ABVP executive of the students' union, also met the chancellor.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 11,2020

New Delhi, May 11: Former prime minister Manmohan Singh is stable and under observation at the AIIMS here after suffering reaction to a new medication and developing fever, hospital sources said on Monday.

The 87-year-old Congress leader was admitted to the hospital on Sunday evening after he complained of uneasiness. He has now been shifted out of the ICU.

The sources said that Singh had developed a reaction to a new medication and further investigation is being carried on him to rule out other causes of fever.

"Dr Manmohan Singh was admitted for observation and investigation after he developed a febrile reaction to a new medication," the sources said.

"He is being investigated to rule out other causes of fever and is being provided care as needed. He is stable and under care of a team of doctors at the Cardiothoracic Centre of AIIMS," they said.

"All his parameters are fine. He is under observation at the AIIMS," a source close to him has said.

Singh, a senior leader of the opposition Congress, is currently a Member of Rajya Sabha from Rajasthan. He was the prime minister between 2004 and 2014.

In 2009, Singh underwent a successful coronary bypass surgery at the AIIMS. A number of leaders expressed have expressed concern over his health and wished him a speedy recovery.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 4,2020

The government suspended all the India-bound air travel from China and has declared all visas 'invalid', on Monday, due to the rapid escalation of cases of novel coronavirus outbreak which originated in Wuhan.

"Embassy and our Consulates have been receiving several queries from Chinese citizens as well as other foreign nationals, who are based out of China or visited China in the last 2 weeks, as to whether they can use their valid single/multiple entry visas to travel to India," tweeted the Embassy of India in Beijing, China.

"It is clarified that existing visas are no longer valid. Intending visitors to India should contact the Indian Embassy in Beijing ([email protected]) or the Consulates in Shanghai ([email protected]) and Guangzhou ([email protected]) to apply afresh for an Indian visa," it said.

Further, regarding the validity of visas, the embassy said, "Indian Visa Application Centres (http://blsindia-china.com) in these cities may also be contacted in this regard. Visa Section of the Embassy/Consulates of India in China can be contacted to ascertain the validity of visa before undertaking any visit to India."

"All those who are already in India (with regular or e-visa) and had traveled from China after January 15 are requested to contact the hotline number of Ministry of Health and Family Welfare of Government of India (+91-11-23978046 and email: [email protected])," the embassy said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.